These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22678011)

  • 1. Preliminary proteomic-based identification of a novel protein for Down's syndrome in maternal serum.
    Yu B; Zhang B; Wang J; Wang QW; Huang RP; Yang YQ; Shao SH
    Exp Biol Med (Maywood); 2012 May; 237(5):530-9. PubMed ID: 22678011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.
    Nagalla SR; Canick JA; Jacob T; Schneider KA; Reddy AP; Thomas A; Dasari S; Lu X; Lapidus JA; Lambert-Messerlian GM; Gravett MG; Roberts CT; Luthy D; Malone FD; D'Alton ME
    J Proteome Res; 2007 Apr; 6(4):1245-57. PubMed ID: 17373838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
    Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
    Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.
    Kang Y; Dong X; Zhou Q; Zhang Y; Cheng Y; Hu R; Su C; Jin H; Liu X; Ma D; Tian W; Li X
    Prenat Diagn; 2012 Mar; 32(3):284-92. PubMed ID: 22430729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on key techniques and intervention in reducing birth defects].
    Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and identification of potential predictive biomarkers for Down's syndrome from second trimester maternal serum.
    Yao Y; Jiang Y; Han M; Xia Y; He Y; Wang Y; Luo Y; Zhang B
    Expert Rev Proteomics; 2015 Feb; 12(1):97-107. PubMed ID: 25434962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of free fetal DNA with beta-human chorionin gonadotropin in circulation in pregnant women with high risk of Down's syndrome].
    Meng JL; Wang XT; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):661-4. PubMed ID: 20079176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening.
    Koster MP; Pennings JL; Imholz S; Rodenburg W; Visser GH; de Vries A; Schielen PC
    Prenat Diagn; 2009 Sep; 29(9):857-62. PubMed ID: 19488973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new biomarkers for Down's syndrome in maternal plasma.
    Heywood W; Mills K; Wang D; Hogg J; Madgett TE; Avent ND; Chitty LS
    J Proteomics; 2012 May; 75(9):2621-8. PubMed ID: 22456345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased time-to-pregnancy and first trimester Down's syndrome screening.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Hum Reprod; 2010 Feb; 25(2):412-7. PubMed ID: 19945962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.
    Ognibene A; Ciuti R; Tozzi P; Messeri G
    Prenat Diagn; 1999 Nov; 19(11):1058-60. PubMed ID: 10589060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 11-13 weeks?
    Mastricci AL; Akolekar R; Kuppusamy R; Ahmed M; Nicolaides KH
    Fetal Diagn Ther; 2011; 30(1):53-9. PubMed ID: 21422752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
    Cowans NJ; Spencer K
    Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
    Weisz B; Rodeck CH
    Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum müllerian-inhibiting substance in Down's syndrome pregnancies.
    Seifer DB; MacLaughlin DT; Cuckle HS
    Hum Reprod; 2007 Apr; 22(4):1017-20. PubMed ID: 17218369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.